Brown Brothers Harriman & Co. »

Lineage Cell Therapeutics In shares owned by Brown Brothers Harriman & Co.

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Brown Brothers Harriman & Co. from 13F filings

Historical chart of Brown Brothers Harriman & Co. investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Brown Brothers Harriman & Co. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Brown Brothers Harriman & Co.

Quarter filed Position value Share count Share price at filing
2026-03-31 $15k 9.4k 1.58

More positions owned by Brown Brothers Harriman & Co.

Ishares Core S&p 500 Etf Common Stock (IVV)
Alphabet Inc-cl C Common Stock (GOOG)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Akre Focus Etf Common Stock (AKRE)
Berkshire Hathaway Inc-cl B Common Stock (BRK.B)
Kla Corp Common Stock (KLAC)
Amazon.com Common Stock (AMZN)
Bbh Select Mid Cap Etf Common Stock (BBHM)
Bbh Select Large Cap Etf Common Stock (BBHL)
Ishares Core Msci Eafe Etf Common Stock (IEFA)
Waste Management Common Stock (WM)
Mastercard Inc - A Common Stock (MA)
Linde Common Stock (LIN)
Nvidia Corp Common Stock (NVDA)

View all positions for Brown Brothers Harriman & Co.

Top funds holding Lineage Cell Therapeutics In

Broadwood Capital
Vanguard Group
Vanguard Capital Management
Defender Capital
Millennium Management
Raffles Associates
Fifth Third Bancorp
Brian McDonald
BlackRock
Armistice Capital
Geode Capital Management
Renaissance Technologies
Morgan Stanley
UBS Group
Marshall Wace

View all funds holding Lineage Cell Therapeutics In